STCube Inc (052020) - Net Assets
Based on the latest financial reports, STCube Inc (052020) has net assets worth ₩65.58 Billion KRW (≈ $44.44 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩83.59 Billion ≈ $56.65 Million USD) and total liabilities (₩18.02 Billion ≈ $12.21 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 052020 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩65.58 Billion |
| % of Total Assets | 78.45% |
| Annual Growth Rate | 9.6% |
| 5-Year Change | 346.17% |
| 10-Year Change | 146.66% |
| Growth Volatility | 76.2 |
STCube Inc - Net Assets Trend (2009–2025)
This chart illustrates how STCube Inc's net assets have evolved over time, based on quarterly financial data. See how many days can STCube Inc fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for STCube Inc (2009–2025)
The table below shows the annual net assets of STCube Inc from 2009 to 2025. For live valuation and market cap data, see market value of STCube Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩72.12 Billion ≈ $48.88 Million |
-23.50% |
| 2024-12-31 | ₩94.28 Billion ≈ $63.89 Million |
+167.01% |
| 2023-12-31 | ₩35.31 Billion ≈ $23.93 Million |
-31.07% |
| 2022-12-31 | ₩51.22 Billion ≈ $34.71 Million |
+216.87% |
| 2021-12-31 | ₩16.16 Billion ≈ $10.95 Million |
-55.13% |
| 2020-12-31 | ₩36.03 Billion ≈ $24.41 Million |
+25.02% |
| 2019-12-31 | ₩28.82 Billion ≈ $19.53 Million |
-25.54% |
| 2018-12-31 | ₩38.70 Billion ≈ $26.23 Million |
+102.40% |
| 2017-12-31 | ₩19.12 Billion ≈ $12.96 Million |
-34.60% |
| 2016-12-31 | ₩29.24 Billion ≈ $19.81 Million |
+39.82% |
| 2015-12-31 | ₩20.91 Billion ≈ $14.17 Million |
-2.56% |
| 2014-12-31 | ₩21.46 Billion ≈ $14.54 Million |
+96.48% |
| 2013-12-31 | ₩10.92 Billion ≈ $7.40 Million |
+24.30% |
| 2012-12-31 | ₩8.79 Billion ≈ $5.96 Million |
-11.88% |
| 2011-12-31 | ₩9.97 Billion ≈ $6.76 Million |
-15.03% |
| 2010-12-31 | ₩11.74 Billion ≈ $7.95 Million |
-29.45% |
| 2009-12-31 | ₩16.63 Billion ≈ $11.27 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to STCube Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 14458933873100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩218.55 Billion | 303.03% |
| Total Equity | ₩72.12 Billion | 100.00% |
STCube Inc Competitors by Market Cap
The table below lists competitors of STCube Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Information Services Group Inc
NASDAQ:III
|
$199.01 Million |
|
Bicycle Therapeutics plc
F:50BA
|
$199.05 Million |
|
Shalby Limited
NSE:SHALBY
|
$199.14 Million |
|
TBS Energi Utama Tbk PT
JK:TOBA
|
$199.15 Million |
|
Kontrolmatik Teknoloji Enerji ve Mu
IS:KONTR
|
$198.87 Million |
|
LENZ Therapeutics Inc
NASDAQ:LENZ
|
$198.79 Million |
|
PAMT CORP
NASDAQ:PAMT
|
$198.76 Million |
|
CviLux Corp
TW:8103
|
$198.71 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in STCube Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 94,275,894,290 to 72,121,558,590, a change of -22,154,335,700 (-23.5%).
- Net loss of 21,799,678,280 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-21.80 Billion | -30.23% |
| Other Changes | ₩-354.66 Million | -0.49% |
| Total Change | ₩- | -23.50% |
Book Value vs Market Value Analysis
This analysis compares STCube Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 10.33x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 10.91x to 10.33x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1005.79 | ₩10970.00 | x |
| 2017-12-31 | ₩634.80 | ₩10970.00 | x |
| 2018-12-31 | ₩1279.91 | ₩10970.00 | x |
| 2019-12-31 | ₩937.49 | ₩10970.00 | x |
| 2020-12-31 | ₩1008.25 | ₩10970.00 | x |
| 2021-12-31 | ₩449.67 | ₩10970.00 | x |
| 2022-12-31 | ₩1121.39 | ₩10970.00 | x |
| 2023-12-31 | ₩763.78 | ₩10970.00 | x |
| 2024-12-31 | ₩1387.77 | ₩10970.00 | x |
| 2025-12-31 | ₩1061.65 | ₩10970.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently STCube Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -30.23%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -312.14%
- • Asset Turnover: 0.08x
- • Equity Multiplier: 1.25x
- Recent ROE (-30.23%) is above the historical average (-40.73%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | -14.65% | -19.78% | 0.62x | 1.20x | ₩-4.10 Billion |
| 2010 | 7.33% | 4.85% | 1.13x | 1.34x | ₩-313.38 Million |
| 2011 | -46.53% | -62.53% | 0.48x | 1.55x | ₩-5.64 Billion |
| 2012 | -17.08% | -13.36% | 0.82x | 1.56x | ₩-2.38 Billion |
| 2015 | -26.31% | -117.10% | 0.20x | 1.12x | ₩-7.59 Billion |
| 2016 | -21.43% | -41.06% | 0.37x | 1.39x | ₩-9.19 Billion |
| 2017 | -86.05% | -194.47% | 0.32x | 1.38x | ₩-18.37 Billion |
| 2018 | -27.66% | -102.26% | 0.18x | 1.51x | ₩-14.58 Billion |
| 2019 | -41.81% | -69.28% | 0.33x | 1.82x | ₩-14.93 Billion |
| 2020 | -44.28% | -157.58% | 0.20x | 1.40x | ₩-19.55 Billion |
| 2021 | -133.19% | -271.64% | 0.31x | 1.60x | ₩-23.15 Billion |
| 2022 | -36.88% | -299.76% | 0.10x | 1.19x | ₩-24.01 Billion |
| 2023 | -69.39% | -420.43% | 0.13x | 1.30x | ₩-28.03 Billion |
| 2024 | -22.74% | -189.74% | 0.10x | 1.19x | ₩-30.86 Billion |
| 2025 | -30.23% | -312.14% | 0.08x | 1.25x | ₩-29.01 Billion |
Industry Comparison
This section compares STCube Inc's net assets metrics with peer companies in the Electronic Equipment & Parts industry.
Industry Context
- Industry: Electronic Equipment & Parts
- Average net assets among peers: $85,057,557,303
- Average return on equity (ROE) among peers: 6.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| STCube Inc (052020) | ₩65.58 Billion | -14.65% | 0.27x | $198.91 Million |
| SANGBO Corp (027580) | $62.63 Billion | 0.70% | 0.88x | $37.61 Million |
| Inzi Display Co.Ltd (037330) | $154.09 Billion | 16.03% | 1.30x | $26.75 Million |
| BioSmart Co.Ltd (038460) | $35.23 Billion | 0.95% | 0.96x | $37.64 Million |
| e-LITECOM CO. Ltd (041520) | $38.24 Billion | 17.41% | 1.56x | $75.57 Million |
| CoAsia Corporation (045970) | $103.88 Billion | -2.68% | 2.93x | $51.24 Million |
| Powerlogics Co. Ltd (047310) | $117.60 Billion | 14.56% | 1.21x | $93.31 Million |
| Phoenix Materials Co. Ltd (050090) | $27.87 Billion | -10.27% | 0.20x | $28.03 Million |
| CammSys Corp (050110) | $75.36 Billion | 10.73% | 0.88x | $48.19 Million |
| Amotech Co. Ltd (052710) | $150.61 Billion | 10.37% | 1.38x | $189.96 Million |
About STCube Inc
STCube, Inc., a biopharmaceutical company, develops therapies to treat novel immune evasion mechanisms in cancer in South Korea. Its platforms include STGlyTarget that is used for the identification and development of immunomodulatory proteins; Immunomodulator Discovery Platform, a proprietary technology to screen for immunomodulatory proteins; Glyco-Specific Antibody Development Platform, a tech… Read more